InvestorsHub Logo
Followers 11
Posts 2417
Boards Moderated 2
Alias Born 02/24/2018

Re: None

Thursday, 01/17/2019 5:51:38 AM

Thursday, January 17, 2019 5:51:38 AM

Post# of 205165
Encouraging feedback from Mark:

I had an e-mail exchange with Mark yesterday. His remarks were candid and encouraging...justifying further patience in my opinion.

On Jan 16, 2019, at 4:55 AM, I wrote the following:

Dr. Mark Schena Ph.D., President Arrayit Corporation

Mark,

As a long time investor in Arrayit I continue to be impressed with the progress being made in the company, especially in the past couple of years. Having said this, investor confidence and the stock share price continue to erode due to the delayed issuance of SEC filings. I'm sure there are justifiable reasons for these delays.

During this SEC filing hiatus there are several actions you might want to consider to boost investor confidence and share price. First, although the directors have significant holdings in preferred stock, it would send a vote of confidence to shareholders for directors to purchase shares of the common stock in the open market. Second, since the company appears to have developed a steady cash flow, it might be wise to use some of these funds to buy back shares of common stock and retire them from the authorized amount with the goal of reducing the outstanding shares to under the psychological threshold of a billion shares.

Also, I question the value-added proposition of having daily semi-celebrity endorsements. As an investor, I don't see the benefit from spending monies on these continuing endorsements. What I would appreciate would be endorsements from doctors and clinics using Arrayit products.

I appreciate you taking the time to consider these suggestions.

Best regards,

Ray H.

Dear Ray, We appreciate your support and feedback. The financials are on schedule, following the industry standard 8-12 weeks per fiscal year. We will be listing on Nasdaq with the current outstanding share count. Resources are being devoted to revenues and earnings growth. Your suggestion on physician endorsements is excellent and in progress. Thanks, Mark

https://www.nasdaq.com/press-release/arrayit-corporation-aces-fourth-consecutive-round-of-proficiency-testing-with-a-top-proficiency-20190114-00132